Literature DB >> 14252072

ACUTE OBSTRUCTIVE CHOLANGITIS.

W OSTERMILLER, R J THOMPSON, R CARTER, D B HINSHAW.   

Abstract

Keywords:  ADENOCARCINOMA; BILE DUCT NEOPLASMS; CHLORAMPHENICOL; CHOLANGITIS; COMMON BILE DUCT CALCULI; DRUG THERAPY; GERIATRICS; SURGERY, OPERATIVE; TETRACYCLINE

Mesh：

Substances：

Year:  1965        PMID： 14252072     DOI： 10.1001/archsurg.1965.01320090070016

Source DB:  PubMed          Journal:  Arch Surg        ISSN： 0004-0010


× No keyword cloud information.
  8 in total

Review 1.  Radiologic approach to malignant biliary obstruction: review and commentary.

Authors:  E J Ring
Journal:  Cardiovasc Intervent Radiol       Date:  1990 Aug-Sep       Impact factor: 2.740

2.  Acute obstructive suppurative cholangitis.

Authors:  R W Dow; S M Lindenauer
Journal:  Ann Surg       Date:  1969-02       Impact factor: 12.969

3.  Pathogenesis and clinical features of acute cholangitis accompanied by shock.

Authors:  H Shimada; G Nakagawara; M Kobayashi; S Tsuchiya; T Kudo; S Morita
Journal:  Jpn J Surg       Date:  1984-07

4.  Emergency decompression of bile duct in acute obstructive suppurative cholangitis by duodenoscopic cannulation: a lifesaving procedure.

Authors:  S Ikeda; M Tanaka; H Itoh; H Kishikawa; F Nakayama
Journal:  World J Surg       Date:  1981-07       Impact factor: 3.352

5.  The clinical and pathologic correlations in mechanical biliary obstruction and acute cholangitis.

Authors:  M J O'Connor; H W Sumner; M L Schwartz
Journal:  Ann Surg       Date:  1982-04       Impact factor: 12.969

6.  Acute cholangitis.

Authors:  J H Boey; L W Way
Journal:  Ann Surg       Date:  1980-03       Impact factor: 12.969

7.  Acute cholangitis. Multivariate analysis of risk factors.

Authors:  J F Gigot; T Leese; T Dereme; J Coutinho; D Castaing; H Bismuth
Journal:  Ann Surg       Date:  1989-04       Impact factor: 12.969

8.  Cholangitis due to malignant obstruction of biliary outflow.

Authors:  M J O'Connor; M L Schwartz; D G McQuarrie; H W Sumner
Journal:  Ann Surg       Date:  1981-03       Impact factor: 12.969
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.